Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004307
Filing Date
2018-05-08
Accepted
2018-05-08 16:16:12
Documents
50
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20180331x10q.htm 10-Q 1523112
2 EX-10.0 ardx-20180331ex100e97155.htm EX-10.0 81153
3 EX-10.1 ardx-20180331ex101b83033.htm EX-10.1 81193
4 EX-31.1 ardx-20180331ex3116ee339.htm EX-31.1 22329
5 EX-31.2 ardx-20180331ex31248ab4a.htm EX-31.2 22313
6 EX-32.1 ardx-20180331ex321df727f.htm EX-32.1 16827
  Complete submission text file 0001558370-18-004307.txt   5147388

Data Files

Seq Description Document Type Size
7 EX-101.INS ardx-20180331.xml EX-101.INS 1158276
8 EX-101.SCH ardx-20180331.xsd EX-101.SCH 27068
9 EX-101.CAL ardx-20180331_cal.xml EX-101.CAL 41350
10 EX-101.DEF ardx-20180331_def.xml EX-101.DEF 83179
11 EX-101.LAB ardx-20180331_lab.xml EX-101.LAB 205864
12 EX-101.PRE ardx-20180331_pre.xml EX-101.PRE 173025
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 18814760
SIC: 2834 Pharmaceutical Preparations